Why did the EU tighten arachidonic acid imports?
New import checks follow a contamination link
European regulators recently moved to tighten controls on shipments of arachidonic acid oil coming from China after that ingredient was connected to contamination in batches of infant formula. The action is a precaution aimed at preventing further instances of the specific toxin that prompted recalls and consumer alarm.
Health authorities tied the contamination to cereulide, a toxin that can be produced by some bacteria and that led to large, cross-border recalls of formula across Europe. With infant formula, even low-probability hazards draw intense scrutiny because the product is given to a highly vulnerable population. In response, customs and food-safety agencies are increasing documentary checks, sampling and laboratory testing on imports of the oil until they are satisfied production and safety controls are reliable.
What this means in practice
- Importers can expect more paperwork and longer hold times at border control while samples are taken.
- Manufacturers that use the oil in finished products will need to demonstrate tighter supplier verification and testing results.
- Regulators will likely coordinate more closely across member states to share test results and red flags.
Why it matters
Tighter controls reduce the immediate risk that contaminated batches reach store shelves and reassure parents and health professionals. The moves also increase pressure on supply chains: companies sourcing the ingredient may face delays or need to find alternative suppliers, and smaller manufacturers could confront higher costs from added testing. At the regulatory level, the step signals a low tolerance for repeat incidents and may prompt broader reviews of how novel or imported nutritional oils are certified for use in infant foods.
Some details remain unclear. It’s still uncertain how long the controls will remain in place, how many shipments will be affected, or whether exporters will change production practices to meet the new scrutiny.